share_log

君聖泰醫藥-B:於二零二四年五月十六日舉行的股東週年大會投票結果

HIGHTIDE-B: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 16, 2024

Hong Kong Stock Exchange ·  May 16 19:35
Summary by Futu AI
君圣泰医药-B於2024年5月16日透過虛擬會議方式舉行了股東週年大會,會上通過了包括財務報表的採納、董事的重選及核數師的續聘等多項普通決議案。所有決議案均獲得100%的贊成票,顯示出股東對公司管理層的高度支持。此外,股東亦通過了授權董事會配發及購回股份的決議案。股東週年大會由公司董事會主席兼行政總裁劉利平博士主持,並有其他董事成員出席。會議結果顯示,股東對公司的經營方針和未來發展持正面態度。
君圣泰医药-B於2024年5月16日透過虛擬會議方式舉行了股東週年大會,會上通過了包括財務報表的採納、董事的重選及核數師的續聘等多項普通決議案。所有決議案均獲得100%的贊成票,顯示出股東對公司管理層的高度支持。此外,股東亦通過了授權董事會配發及購回股份的決議案。股東週年大會由公司董事會主席兼行政總裁劉利平博士主持,並有其他董事成員出席。會議結果顯示,股東對公司的經營方針和未來發展持正面態度。
Jun Sung Tai Pharmaceutical-B held its Annual General Meeting via virtual meeting on 16 May 2024 and adopted a number of ordinary resolutions including adoption of financial statements, re-election of directors and renewal of auditors. ALL RESOLUTIONS RECEIVED 100% APPROVAL, SHOWING THE HIGH LEVEL OF SHAREHOLDERS' SUPPORT FOR THE COMPANY'S MANAGEMENT. In addition, shareholders have also passed resolutions authorizing the Board to distribute and repurchase shares. The Annual General Meeting was chaired by Dr. Liu Liping, Chairman of the Board and Chief Executive Officer of the Company, and was attended by other members of the Board of Directors. The results of the meeting showed that shareholders have a positive attitude towards the company's business policy and future development.
Jun Sung Tai Pharmaceutical-B held its Annual General Meeting via virtual meeting on 16 May 2024 and adopted a number of ordinary resolutions including adoption of financial statements, re-election of directors and renewal of auditors. ALL RESOLUTIONS RECEIVED 100% APPROVAL, SHOWING THE HIGH LEVEL OF SHAREHOLDERS' SUPPORT FOR THE COMPANY'S MANAGEMENT. In addition, shareholders have also passed resolutions authorizing the Board to distribute and repurchase shares. The Annual General Meeting was chaired by Dr. Liu Liping, Chairman of the Board and Chief Executive Officer of the Company, and was attended by other members of the Board of Directors. The results of the meeting showed that shareholders have a positive attitude towards the company's business policy and future development.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.